Evidence map›Paper›PMID 33085207›Full record

ArticleHIV medicine2021

Cognitive ageing is premature among a community sample of optimally treated people living with HIV.

H L Aung, M Bloch, T Vincent, D Quan, A Jayewardene, Z Liu, T M Gates, B Brew, L Mao, L A Cysique

Open access · hybridAbstract read
In one paragraph

Article in HIV medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

H L AungDepartment of Neurology and HIV Medicine, St Vincent's Hospital and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.ORCID 0000-0002-8867-3220
M BlochFaculty of Medicine, UNSW, Sydney, NSW, Australia.ORCID 0000-0002-1143-5013
T VincentHoldsworth House Medical Practice, Sydney, NSW, Australia.
D QuanHoldsworth House Medical Practice, Sydney, NSW, Australia.
A JayewardeneHoldsworth House Medical Practice, Sydney, NSW, Australia.ORCID 0000-0002-7360-0221
Z LiuStats Central, UNSW, Sydney, NSW, Australia.ORCID 0000-0003-3337-0692
T M GatesDepartment of Neurology and HIV Medicine, St Vincent's Hospital and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.ORCID 0000-0003-0113-8282
B BrewDepartment of Neurology and HIV Medicine, St Vincent's Hospital and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.ORCID 0000-0003-0622-1392
L MaoCentre for Social Research in Health, UNSW, Sydney, NSW, Australia.ORCID 0000-0003-0995-5789
L A CysiqueDepartment of Neurology and HIV Medicine, St Vincent's Hospital and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, Sydney, NSW, Australia.ORCID 0000-0002-7711-6373
UNSW Sydney · AUSt Vincent's Hospital Melbourne · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesEvidence of premature cognitive ageing amongst people living with HIV (PLHIV) remains controversial due to previous research limitations including underpowered studies, samples with suboptimal antiretroviral access, varying rate of virological control, high rate of AIDS, over-representation of non-community samples, and inclusion of inappropriate controls. The current study addresses these limitations, while also considering mental health and non-HIV comorbidity burden to determine whether PLHIV showed premature cognitive ageing compared with closely comparable HIV-negative controls.

methodsThis study enrolled 254 PLHIV [92% on antiretroviral therapy; 84% with HIV RNA < 50 copies/mL; 15% with AIDS) and 72 HIV-negative gay and bisexual men [mean (SD) age = 49 (10.2) years] from a single primary care clinic in Sydney, Australia. Neurocognitive function was evaluated with the Cogstate Computerized Battery (CCB) at baseline and 6 months after. Linear mixed-effects (LME) models examined main and interaction effects of HIV status and chronological age on the CCB demographically uncorrected global neurocognitive z-score (GZS), adjusting for repeated testing, and then adjusting sequentially for HIV disease markers, mental health and comorbidities.

resultsHIV status and age interacted with a lower GZS (β = -0.43, P < 0.05). Higher level of anxiety symptoms (β = -0.11, P < 0.01), historical AIDS (β = -0.12, P < 0.05) and historical HIV brain involvement (β = -0.12, P < 0.05) were associated with lower GZS.

conclusionsWe found a robust medium-sized premature ageing effect on cognition in a community sample with optimal HIV care. Our study supports routine screening of cognitive and mental health among PLHIV aged ≥ 50 years.

Indexed as

Cognitive AgingHIV InfectionsAnti-Retroviral AgentsCognitionComorbidityHumansMaleMiddle AgedAnti-Retroviral Agentscognitive ageingHIVpremature ageing

Identifiers

PMID33085207
PMCPMC7984032
OpenAlexW3093999672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.